On February 11, the US Food and Drug Administration (FDA) authorized the emergency use of the monoclonal antibody bebtelovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients when all of these apply:
CMS Delays Hospital Star Ratings Update Until July 2022
The Centers for Medicare & Medicaid Services (CMS) announced that it will delay updating the Overall Hospital Quality Star Ratings on the Care Compare website from April until July 2022 so it can correct a calculation error in the calendar year 2021 results for the OP-10 outpatient imaging efficiency measure.
CMS Expands Medicare Coverage For Lung Cancer Screening
The Centers for Medicare & Medicaid Services (CMS) announced a national coverage determination (NCD) that expands coverage for lung cancer screening with low dose computed tomography (LDCT) to improve health outcomes for people with lung cancer.
New HCPCS Code For Convalescent Plasma In Outpatient Setting
On December 28, the US Food and Drug Administration (FDA) revised the emergency use authorization for COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies.
CPT Update For Pediatric COVID-19 Vaccine Announced
The American Medical Association (AMA) announced an editorial update to the Current Procedural Terminology (CPT) code set to include new product and administration codes assigned to the Pfizer-BioNTech COVID-19 vaccine for children 6 months to under 5 years of age.
